Development and use of iron oxide nanoparticles (part 2)

The application of iron oxide contrast agents in MRI

G. Mandarano, J. Lodhia, P. Eu, N. J. Ferris, R. Davidson, S. F. Cowell

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

Magnetic resonance imaging (MRI) is a medical imaging tool that can incorporate contrast agents to enhance its ability to identify and characterise pathologies. MRI contrast agents can be paramagnetic such as gadolinium, or superparamagnetic such as iron oxide. Significant concerns of Nephrogenic Systemic Fibrosis (NSF) have arisen involving gadolinium-based contrast media. Recent research has focused on iron oxide nanoparticles because their sizes are more comparable to biological units. These can give MRI the potential to detect a broader range of pathology, while also track and observe biological processes. This is the second article of a two-part series and will review iron oxide nanoparticles as a MRI contrast agent, and the potential applications of iron oxide nanoparticles to a range of pathologies and processes involving MRI.

Original languageEnglish
Pages (from-to)1-14
Number of pages14
JournalBiomedical Imaging and Intervention Journal
Volume6
Issue number2
DOIs
Publication statusPublished - 1 Apr 2010

Fingerprint

Iron oxides
Nanoparticles
Magnetic resonance imaging
Contrast Media
Magnetic Resonance Imaging
Pathology
Gadolinium
Nephrogenic Fibrosing Dermopathy
Contrast media
Biological Phenomena
Medical imaging
Diagnostic Imaging
ferric oxide
Research

Cite this

@article{d6de4e1eed36468eb5dacc1b4f008afd,
title = "Development and use of iron oxide nanoparticles (part 2): The application of iron oxide contrast agents in MRI",
abstract = "Magnetic resonance imaging (MRI) is a medical imaging tool that can incorporate contrast agents to enhance its ability to identify and characterise pathologies. MRI contrast agents can be paramagnetic such as gadolinium, or superparamagnetic such as iron oxide. Significant concerns of Nephrogenic Systemic Fibrosis (NSF) have arisen involving gadolinium-based contrast media. Recent research has focused on iron oxide nanoparticles because their sizes are more comparable to biological units. These can give MRI the potential to detect a broader range of pathology, while also track and observe biological processes. This is the second article of a two-part series and will review iron oxide nanoparticles as a MRI contrast agent, and the potential applications of iron oxide nanoparticles to a range of pathologies and processes involving MRI.",
keywords = "Iron oxide nanoparticles, MRI",
author = "G. Mandarano and J. Lodhia and P. Eu and Ferris, {N. J.} and R. Davidson and Cowell, {S. F.}",
year = "2010",
month = "4",
day = "1",
doi = "10.2349/biij.6.2.e13",
language = "English",
volume = "6",
pages = "1--14",
journal = "Biomedical Imaging and Intervention Journal: a multidisciplinary open access online journal",
issn = "1823-5530",
publisher = "University of Malaya",
number = "2",

}

Development and use of iron oxide nanoparticles (part 2) : The application of iron oxide contrast agents in MRI. / Mandarano, G.; Lodhia, J.; Eu, P.; Ferris, N. J.; Davidson, R.; Cowell, S. F.

In: Biomedical Imaging and Intervention Journal, Vol. 6, No. 2, 01.04.2010, p. 1-14.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Development and use of iron oxide nanoparticles (part 2)

T2 - The application of iron oxide contrast agents in MRI

AU - Mandarano, G.

AU - Lodhia, J.

AU - Eu, P.

AU - Ferris, N. J.

AU - Davidson, R.

AU - Cowell, S. F.

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Magnetic resonance imaging (MRI) is a medical imaging tool that can incorporate contrast agents to enhance its ability to identify and characterise pathologies. MRI contrast agents can be paramagnetic such as gadolinium, or superparamagnetic such as iron oxide. Significant concerns of Nephrogenic Systemic Fibrosis (NSF) have arisen involving gadolinium-based contrast media. Recent research has focused on iron oxide nanoparticles because their sizes are more comparable to biological units. These can give MRI the potential to detect a broader range of pathology, while also track and observe biological processes. This is the second article of a two-part series and will review iron oxide nanoparticles as a MRI contrast agent, and the potential applications of iron oxide nanoparticles to a range of pathologies and processes involving MRI.

AB - Magnetic resonance imaging (MRI) is a medical imaging tool that can incorporate contrast agents to enhance its ability to identify and characterise pathologies. MRI contrast agents can be paramagnetic such as gadolinium, or superparamagnetic such as iron oxide. Significant concerns of Nephrogenic Systemic Fibrosis (NSF) have arisen involving gadolinium-based contrast media. Recent research has focused on iron oxide nanoparticles because their sizes are more comparable to biological units. These can give MRI the potential to detect a broader range of pathology, while also track and observe biological processes. This is the second article of a two-part series and will review iron oxide nanoparticles as a MRI contrast agent, and the potential applications of iron oxide nanoparticles to a range of pathologies and processes involving MRI.

KW - Iron oxide nanoparticles

KW - MRI

UR - http://www.scopus.com/inward/record.url?scp=79954993105&partnerID=8YFLogxK

UR - http://www.biij.org/2010/2/e13/

U2 - 10.2349/biij.6.2.e13

DO - 10.2349/biij.6.2.e13

M3 - Review article

VL - 6

SP - 1

EP - 14

JO - Biomedical Imaging and Intervention Journal: a multidisciplinary open access online journal

JF - Biomedical Imaging and Intervention Journal: a multidisciplinary open access online journal

SN - 1823-5530

IS - 2

ER -